-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Astrana Health, Lowers Price Target to $45

Benzinga·11/07/2025 19:38:46
Listen to the news
BTIG analyst David Larsen maintains Astrana Health (NASDAQ:ASTH) with a Buy and lowers the price target from $50 to $45.